Skip to main content

Table 1 Pharmacological agents used for reverse microdialysis

From: Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo

Compound

Target

IC50 or Ki

Rev MD Concentration

Dosage Across MD Membrane

Selectivity Limit

Reference

Agonists

      

Ipsapirone

5-HT1AR

10 nM

1 μM

100 nM

58 nMa

[59]

WAY161503

5-HT2CR

4 nM

400 nM

40 nM

233 nM

[60]

ML10302

5-HT4R

4 nM

400 nM

40 nM

700 nM

[61]

ST1936

5-HT6R

13 nM

1.3 μM

130 nM

168 nM

[62]

AS19

5-HT7R

0.83 nM

83 nM

8.3 nM

6.6 nMb

[63]

Antagonists

      

GR113808

5-HT4R

0.02 nM

100 nM

10 nM

10 μM

[64]

SB258719

5-HT7R

31.6 nM

3.16 μM

316 nM

316 nM

[68]

Inhibitors

      

GM6001

ADAM/MMP

0.5 nM-27 nM

2.5 μM

250 nM

NA

[66]

KT5720

PKA

60 nM

6 μM

600 nM

2 μM

[67]

PKI14-22

PKA

36 nM

3.6 μM

360 nM

15 μM

[65]

  1. All agents were chosen for their selectivity for their targets as assayed in previous literature. We used the Ki and IC50 values to determine necessary concentrations of each compound (reverse microdialysis (Rev MD) concentration). We assumed only 10 % of the drug would cross the membrane (Dosage Across MD membrane), and this amount of the compound would be further diluted in the brain ISF. The selectivity limit is the concentration above which each compound begins stimulating off-target receptors
  2. aIpsapirone has been shown to stimulate bovine α-adrenergic receptors at 58 nM in vitro [59]
  3. bAS19 can stimulate 5-HT1DR at 6.6 nM concentrations in vitro [63]. However, expression of this receptor is absent in adult mouse hippocampus [14], so effects of its stimulation should be neglible
  4. Abbreviations: 5-HTR serotonin receptor, ADAM a disintegrin and metallopeptidase domain, MMP matrix metallopeptidase, PKA protein kinase A